Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Four-year evaluation of neonatal cystic fibrosis screening in Southern Belgium.

European journal of pediatrics - 21 Nov 2024

Thimmesch M, Berardis S, Hanssens L, Quentin C, Boemer F, Luis G, Dewulf J P, Marie S, Marcelis L, Lefèvre N, Libioulle C, Dideberg V, Philippeau M, Revencu N, Boboli H

Abstract excerpt

Newborn screening for cystic fibrosis (CF-NBS) using an IRT-DNA algorithm with a 12 CFTR-variant panel and an IRT/IRT failsafe was officially implemented in the French-speaking Community of Belgium in January 2020. This screening protocol was evaluated after 4 years according to the criteria defined by the European Cystic Fibrosis Society's working group on neonatal screening. Immunoreactive trypsinogen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Belgium

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Infant, Newborn

Share to Neonatal Screening

Share to Trypsinogen

Source

Identifiers

PMID: 39570414
DOI: 10.1007/s00431-024-05845-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Four-year evaluation of neonatal cystic fibrosis screening in Southern Belgium.PMID 39570414Read ↗

Cystic fibrosis newborn screening in a high prevalence population - Ten years' experience in Ireland.Semantic proximity Read ↗

Newborn screening for CF in France: An exemplary national experience.Semantic proximity Read ↗

Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.Semantic proximity Read ↗

Long-term Outcomes of Pediatric CFSPID: A 15-Year Clinical and Genomic Study Across Newborn Screening Cystic Fibrosis Units.Semantic proximity Read ↗

Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands.Semantic proximity Read ↗

False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10-year experience.Semantic proximity Read ↗

National Newborn Screening for cystic fibrosis in the Republic of Ireland: genetic data from the first 6.5 years.Semantic proximity Read ↗

Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.Semantic proximity Read ↗

Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy.Semantic proximity Read ↗

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.Semantic proximity Read ↗

Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.Semantic proximity Read ↗

Newborn Screening for Cystic Fibrosis in California.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.